Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.58 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | ELANE | P08246 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8465674 | 0.98 | ALDH1A1 (0.63) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| SCHEMBL9152634 | 0.94 | MAPT (0.60) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| Benzophenone SCHEMBL28116793 | 0.93 | ALDH1A1 (0.64) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| SCHEMBL2935942 | 0.91 | ALDH1A1 (0.70) | ALDH1A1HPGDSRD5A2RAB9AHTT | |
| SCHEMBL25525562 | 0.89 | MAPT (0.55) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| SCHEMBL6425819 | 0.89 | SRD5A2 (0.66) | ALDH1A1SRD5A2RAB9AELANEHTT | |
| SCHEMBL382957 | 0.89 | ALDH1A1 (0.53) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| Ethylbenzene SCHEMBL27651621 | 0.88 | RAB9A (0.63) | ALDH1A1HPGDSRD5A2RAB9AELANE | |
| SCHEMBL259581 | 0.88 | L3MBTL1 (0.59) | ALDH1A1HPGDHTTSMN1; SMN2MAPT | |
| SCHEMBL11745992 | 0.88 | ALDH1A1 (0.52) | ALDH1A1HPGDSRD5A2RAB9AELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024083872-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2024-04-25 | — | — | WO | claimed |
| CN-117511385-A | Preparation method of high-hardness friction-resistant hardening coating | 江苏未来像素科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-115528215-A | Secondary battery positive electrode material pre-ionization reagent and preparation method and application thereof | 深圳珈钠能源科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114479735-A | Cationic UV curing adhesive and preparation method and application thereof | 张河远 | 2022-05-13 | — | — | CN | claimed |
| CN-104844466-A | Cardanol group cationic quaternary ammonium salt, preparation method and application thereof | UNIV JIANGXI NORMAL SCI & TECH | 2015-08-19 | — | — | CN | claimed |
| CN-102174074-A | Inhibitors of cancer cell, T cell and keratinocyte proliferation | 4SC AG | 2011-09-07 | — | — | CN | claimed |
| US-7541430-B2 | Peptides for use in treating obesity | NOVO NORDISK A/S (DK) | 2009-06-02 | — | — | US | claimed |
| US-20080207493-A1 | Compounds for Use in the Treatment of Obesity | NOVO NORDISK A/S (DK) | 2008-08-28 | — | — | US | claimed |
| EP-1940345-A1 | HAIR-TREATMENT COMPOSITIONS WITH IMPROVED CARE PERFORMANCE AND METHOD FOR APPLYING THE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2008-07-09 | — | — | EP | claimed |
| EP-1863841-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY | Novo Nordisk A/S (DK) | 2007-12-12 | — | — | EP | claimed |
| US-20070244054-A1 | Peptides for use in treating obesity | NOVO NORDISK A/S (DK) | 2007-10-18 | — | — | US | claimed |
| WO-2007048486-A1 | HAIR-TREATMENT COMPOSITIONS WITH IMPROVED CARE PERFORMANCE AND METHOD FOR APPLYING THE COMPOSITION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-03 | — | — | WO | claimed |
| WO-2006097526-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY | NOVO NORDISK A/S (DK) | 2006-09-21 | — | — | WO | claimed |
| EP-1625158-A2 | PEPTIDES FOR USE IN TREATING OBESITY | NOVO NORDISK A/S (DK) | 2006-02-15 | — | — | EP | claimed |
| WO-2004099246-A2 | PEPTIDES FOR USE IN TREATING OBESITY | NOVO NORDISK A/S (DK) | 2004-11-18 | — | — | WO | claimed |
| WO-1998037982-A1 | ULTRAVIOLET RADIATION CURABLE INKS FOR GAME BALLS, GOLF BALLS AND THE LIKE | ACUSHNET COMPANY (US) | 1998-09-03 | — | — | WO | claimed |
| US-4425404-A | MULTILAYER, PROTECTIVE COATINGS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-4251622-A | CONTAINING A DYE, AN ARYL KETONE SENSITIZER, AND AN N-SUBSTITUTED POLYAMIDE OR A VINYL ACETATE POLYMER OF HIGH MOLECULAR WEIGHT | NIPPON PAINT CO., LTD. (JP) | 1981-02-17 | — | — | US | claimed |
| US-12540247-B2 | Primer composition | THREEBOND CO., LTD. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540247-B2 | Primer composition | FGB, CDH1, F10 | ALDH1A1 1171/4885HPGD 2654/4885SRD5A2 1746/4885 |
| US-20070244054-A1 | Peptides for use in treating obesity | NPY4R, GLP1R, NPY1R | ALDH1A1 4726/4885HPGD 3656/4885SRD5A2 2928/4885 |
| US-20080207493-A1 | Compounds for Use in the Treatment of Obesity | MC4R, MC5R, MC3R | ALDH1A1 2662/4885HPGD 1834/4885SRD5A2 2148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.